Latest News Archive
Please select Category, Year, and then Month to display items
12 October 2020
|
Story Dr Cindé Greyling
|
Photo Supplied
Exercise and nutrition can work wonders for your mental health – you don’t even have to ‘feel like’ or ‘enjoy’ moving around and eating well for it to work – it does its thing anyway.
Nowadays, people talk about mental health like it is the common cold – which is good! But do you know what it really means? Being mentally healthy does not only refer to the absence of a mental illness but includes your emotional and social well-being. One would almost want to add physical well-being too, since a healthy body does indeed support a healthy mind. However, since so many people consider themselves ‘mental health experts’, some myths have been sold as truths.
Myth #1 – You are doomed.
Nope. Never. You are never doomed. There is always help. Mental-health therapies range from self-help, talk therapy, medication, to hospitalisation in some cases. Somewhere on this spectrum of treatments, there will be something that works for you. But you must be willing to get the help and do the work. For starters, exercise and nutrition can work wonders – you do not even have to ‘feel like’ or ‘enjoy’ moving around and eating well for it to work – it does its thing anyway.
Myth #2 – It won’t affect you.
It may. Research suggests that one in five people may suffer from a mental illness at some point in their lives. Being well now does not mean that it will stay that way. Biological and environmental factors both impact your mental health. Hopefully not, but at some point, you may experience an event that affects your mental health.
To remain integrated in a community is always beneficial
for anyone suffering from a mental or physical condition.
Myth #3 – Someone struggling with mental health must be left alone.
Hardly! To remain integrated in a community is always beneficial for anyone suffering from a mental or physical condition. You do not need to fix them, but to remain a friend. Continue to invite them, even if they decline. Do not judge, and do not try to understand. Just stay around.
Go and be kind to yourself, and to those around you.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004